Publications
We have significantly contributed to the understanding of health conditions through real-world data analysis. The insights gained from these studies have had a positive impact on clinical practice, leading to more personalised and effective care for patients.
Incidence and survival of interstitial lung diseases in the UK in 2010–2019
3 Mar 2025
ERJ Open Research
Authors:
Francesca Gonnelli, Neva Eleangovan, Ursie Smith, Vydia Navarantam, Tamera J. Corte, Victoria Carter, David Price, Martina Bonifazi, Richard Hubbard
Keywords:
Interstitial lung disease, Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, Connective Tissue Disease-Interstitial lung disease, Survival, Incidence, Epidemiology
Budesonide/glycopyrrolate/formoterol for the management of COPD in a UK primary care population: real-world use and early medication success
24 May 2024
Int J of COPD
Authors:
Hana Müllerová, Jeffrey Shi Kai Chan, Heath Heatley, Victoria Carter, John Townend, Derek Skinner, Stefan Franzén, Jonathan Marshall, and David Price
Keywords:
Death, Exacerbation, Heart Failure, Myocardial Infarction, Pneumonia
Trends in systemic glucocorticoid utilisation in the United Kingdom from 1990 to 2019: a population-based, serial cross-sectional analysis
15 Mar 2024
Prag Obs Res
Authors:
Andrew N Menzies-Gow,Trung N. Tran, Brooklyn Stanley, Victoria Ann Carter, Josef S. Smolen, Arnaud Bourdin, J. Mark FitzGerald,7† Tim Raine, Jatin Chapaneri, Benjamin Emmanuel, David J. Jackson, David Price
Keywords:
Glucocorticoids, Practice Patterns, Drug Prescriptions, Biological Products, Drug Utilization
The Diagnostic Odyssey in Children and Adolescents With X-linked Hypophosphatemia: Population-Based, Case–Control Study
9 Feb 2024
The Journal of Clinical Endocrinology & Metabolism
Authors:
Freya Boardman-Pretty, Ashley Kieran Clift, Hadley Mahon, Nadine Sawoky, and M. Zulf Mughal
Keywords:
X-linked hypophosphatemia, electronic healthcare records, primary care
Risk of pneumonia in patients with COPD initiating fixed dose inhaled corticosteroid (ICS) / long-acting bronchodilator (LABD) formulations containing extrafine beclometasone dipropionate versus patients initiating LABD without ICS
20 Jan 2024
Prag Obs Res
Authors:
